Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant changes » significant challenge (Expand Search)
significant change » significant challenge (Expand Search), significant challenges (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant changes » significant challenge (Expand Search)
significant change » significant challenge (Expand Search), significant challenges (Expand Search)
-
2021
-
2022
-
2023
FBLN1 regulates ferroptosis by reducing free ferrous iron by inhibiting TGF-β/Smad pathway.
Published 2024Subjects: -
2024
The influence of <i>PINK1</i> on <i>P</i>. <i>berghei</i> infection in <i>A</i>. <i>stephensi</i>.
Published 2024Subjects: -
2025
The influence of 5-HT in mice serum on <i>Plasmodium</i> infection in mosquitoes.
Published 2024Subjects: -
2026
5-HT- induced mitochondrial ROS inhibits <i>P</i>. <i>berghei</i> infection.
Published 2024Subjects: -
2027
-
2028
-
2029
-
2030
-
2031
-
2032
-
2033
-
2034
-
2035
-
2036
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
2037
-
2038
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
2039
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
2040